<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Akande A</submitter><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>94</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12487352</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>Neurogranin (Ng), a known regulator of neuronal Ca²⁺-calmodulin (CaM) signaling, is linked to Alzheimer's disease. Though well-studied in neurons, Ng is also expressed in brain vasculature, where its function remains unclear. To investigate Ng's role in brain microvascular endothelial cells, we defined its interactome using immunoprecipitation-mass spectrometry (IP-MS) under high- and low-Ca²⁺ conditions. Among 119 Ng-binding proteins, we discovered a novel interaction between Ng and MYH9, a key regulator of cytoskeletal remodeling. Ng-MYH9 binding was prominent in high Ca²⁺ and validated via CaM affinity pulldown and proximity ligation assays. Ng knockdown reduced F-actin levels, while MYH9 knockdown decreased both Ng and F-actin. Loss of Ng-MYH9 also impaired AKT-GSK3β signaling and elevated the endothelial activation marker VCAM1. Ng-null mice exhibited disrupted brain microvascular architecture and reduced MYH9 expression in endothelial cells. These findings reveal a novel Ng pathway promoting MYH9-dependent cytoskeletal remodeling and a potential role in maintaining blood-brain barrier integrity, a previously unrecognized function for Ng in brain health and Alzheimer's disease.</pubmed_abstract><journal>Fluids and barriers of the CNS</journal><pubmed_title>Neurogranin-MYH9 interaction regulates cytoskeletal remodeling in cerebral vasculature.</pubmed_title><pmcid>PMC12487352</pmcid><funding_grant_id>P20GM121307</funding_grant_id><funding_grant_id>P20 GM134974</funding_grant_id><funding_grant_id>P20 GM121307</funding_grant_id><pubmed_authors>Park JE</pubmed_authors><pubmed_authors>Akande A</pubmed_authors><pubmed_authors>Scott R</pubmed_authors><pubmed_authors>Nam HW</pubmed_authors><pubmed_authors>Alexander JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurogranin-MYH9 interaction regulates cytoskeletal remodeling in cerebral vasculature.</name><description>Neurogranin (Ng), a known regulator of neuronal Ca²⁺-calmodulin (CaM) signaling, is linked to Alzheimer's disease. Though well-studied in neurons, Ng is also expressed in brain vasculature, where its function remains unclear. To investigate Ng's role in brain microvascular endothelial cells, we defined its interactome using immunoprecipitation-mass spectrometry (IP-MS) under high- and low-Ca²⁺ conditions. Among 119 Ng-binding proteins, we discovered a novel interaction between Ng and MYH9, a key regulator of cytoskeletal remodeling. Ng-MYH9 binding was prominent in high Ca²⁺ and validated via CaM affinity pulldown and proximity ligation assays. Ng knockdown reduced F-actin levels, while MYH9 knockdown decreased both Ng and F-actin. Loss of Ng-MYH9 also impaired AKT-GSK3β signaling and elevated the endothelial activation marker VCAM1. Ng-null mice exhibited disrupted brain microvascular architecture and reduced MYH9 expression in endothelial cells. These findings reveal a novel Ng pathway promoting MYH9-dependent cytoskeletal remodeling and a potential role in maintaining blood-brain barrier integrity, a previously unrecognized function for Ng in brain health and Alzheimer's disease.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-04T01:48:45.681Z</modification><creation>2026-05-04T03:13:57.996Z</creation></dates><accession>S-EPMC12487352</accession><cross_references><pubmed>41029426</pubmed><doi>10.1186/s12987-025-00709-x</doi></cross_references></HashMap>